The eye–mind connection: a systematic review of retinal biomarkers and ocular signatures in major psychiatric disorders Authors: Raha Motamedi, Fatemeh Hayeri Mehrizi, Mohaddeseh Zeinali Ali Abadi, Mohamadreza Mohagheghi, Fatemeh Nourollahi Fomeshi, Seyyede Elahe Mousavikhah, Anis Ghaffarzadeh, Shayan Yaghmayee, Melika Arab Bafrani, Seyyed Kiarash Sadat Rafiei, Daniel Shafiei, Mahsa Asadi Anar, Farbod khosravi, Sanam Faizabadi, Mahdi Bozorgi, Sareh Saien Published: 2025 ABSTRACT BackgroundPsychiatric disorders such as schizophrenia, bipolar disorder, major depression, and dementia are increasingly associated with specific ocular and retinal abnormalities. These associations may reflect shared neurovascular, inflammatory, and neurodegenerative mechanisms, yet findings remain scattered and understudied. This systematic review synthesizes existing evidence on ocular and retinal pathologies across major psychiatric conditions, highlighting common retinal biomarkers that may inform future screening strategies.MethodsFollowing PRISMA 2020 guidelines, a systematic search of PubMed, Scopus, Web of Science, and Embase was conducted. Meta-analysis was initially planned but deemed infeasible due to significant methodological and reporting heterogeneity among eligible studies. Therefore, a structured qualitative synthesis was performed, supported by visual mapping of cross-disorder associations.ResultsSeventeen studies met inclusion criteria, covering major psychiatric conditions including schizophrenia, bipolar disorder, depression, and dementia. Across these disorders, approximately three-quarters of schizophrenia studies (≈75%) reported retinal nerve fiber layer (RNFL) thinning, and two-thirds of dementia studies (≈67%) showed retinal vascular abnormalities or RNFL loss. Glaucoma and dry eye syndrome were the most frequently observed in mood disorders, whereas microvascular dropout was reported in optical coherence tomography angiography (OCT-A) analyses of depression and bipolar disorder. The heatmap visualization highlighted overlapping neuro-ophthalmic signatures, and retinal biomarker analysis identified RNFL thinning and microvascular dropout as potential shared indicators of disease burden.ConclusionThis review emphasizes the emerging evidence for retinal biomarkers as accessible correlates of neuropsychiatric pathology. Although quantitative synthesis was not feasible, the qualitative patterns highlight the need for large-scale, prospective, and biomarker-validation studies integrating ophthalmology and psychiatry. These findings underscore the clinical potential of the brain–retina axis in mental health diagnostics.Supplementary InformationThe online version contains supplementary material available at 10.1186/s40001-025-03664-3. Introduction Cognitive disorders are mental conditions characterized by impairments in memory, reasoning, and judgment resulting from identifiable biological causes, such as neurodegenerative diseases, brain injury, or drug toxicity [1]. These disorders reflect structural or physiological changes in the brain rather than purely psychological disturbances. Their progression varies depending on etiology, while acute injuries or strokes can cause rapid deterioration; neurodegenerative conditions such as Alzheimer’s disease (AD) typically show gradual decline, culminating in severe functional impairment. The increasing prevalence of AD and related dementias poses a growing global health challenge, with more than 8.5 million patients projected in the United States alone by 2030 [2]. Although cognitive disorders represent one spectrum of brain pathology, psychiatric disorders, including schizophrenia, bipolar disorder, and major depressive disorder, share overlapping neurobiological mechanisms involving inflammation, oxidative stress, and vascular dysfunction. Both groups of conditions disrupt neural circuits essential for cognition, emotion, and perception, yet psychiatric disorders are distinguished by their primary behavioral and affective manifestations rather than structural brain lesions. To clarify this distinction, the present review focuses on psychiatric illnesses while acknowledging that neurodegenerative and vascular mechanisms underpinning cognitive decline may also influence ocular health [3]. Emerging evidence suggests that psychiatric disorders are frequently accompanied by specific ocular and retinal changes, including alterations in retinal nerve fiber layer (RNFL) thickness, retinal microvasculature, and visual processing pathways [4]. Since the retina and brain share embryologic origin and vascular characteristics, the eye provides a unique window into central nervous system function. However, despite mounting evidence for a “brain–retina axis”, ocular health remains largely overlooked in psychiatric assessment. Major guidelines such as the American Psychiatric Association’s Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (APA DSM-5-TR, 2022) [5], the National Institute for Health and Care Excellence (NICE) guidelines on mental health (2023) [6], and recommendations from the World Psychiatric Association [7] do not currently include standardized ocular or retinal screening for individuals with mental illness. This diagnostic blind spot delays recognition of comorbid visual impairment and may hinder early detection of neurodegenerative processes mirrored in the retina. Psychiatric disorders, such as schizophrenia, bipolar disorder (BD), and major depressive disorder (MDD), also impose a substantial global disease burden, contributing to disability and premature mortality. While research has primarily focused on the pathophysiology of these conditions, their associations with systemic physical conditions, including ocular diseases, are less well understood [8]. For example, studies have linked BD and MDD to increased risks of vascular diseases through mechanisms such as inflammation, endothelial dysfunction, behavioral factors, and medication side effects. Since the retinal vasculature shares structural and functional similarities with the cerebral vasculature, examining retinal changes offers a unique opportunity to understand central nervous system disorders [9]. Emerging evidence suggests that psychiatric disorders may be associated with specific ocular changes. Retinal vascular abnormalities, such as increased arteriolar tortuosity and changes in vascular branching complexity, have been observed in patients with BD and schizophrenia. Additionally, the retinal ganglion cell layer and retinal nerve fiber layer are thinner in individuals with BD and schizophrenia compared to healthy controls. These findings suggest shared pathophysiological mechanisms between psychiatric disorders and ocular diseases [10]. However, existing studies are limited in number, often cross-sectional in design, and constrained by small sample sizes, making it difficult to draw definitive conclusions [11]. Despite mounting evidence linking psychiatric illness to retinal and visual abnormalities, ocular health remains largely overlooked in psychiatric practice. Major clinical guidelines, including those from the American Psychiatric Association (APA), National Institute for Health and Care Excellence (NICE), and World Psychiatric Association, offer no formal recommendations for routine ocular assessment or retinal imaging in mental health populations. This diagnostic blind spot may contribute to delayed recognition of comorbid visual impairment, missed opportunities for early neurodegenerative detection, and avoidable reductions in quality of life. Addressing this oversight requires systematic evaluation of existing evidence, a gap this review seeks to fill. Despite increasing interest in neuro-ophthalmic correlations, most existing reviews have focused on single disorders, typically schizophrenia or Alzheimer’s disease, or on isolated ocular parameters such as retinal thickness. These fragmented approaches have limited insight into shared retinal biomarkers across psychiatric conditions and have rarely integrated visualization or comparative mapping of cross-disorder patterns. To date, no systematic review has synthesized ocular findings across multiple psychiatric and neuropsychiatric disorders within a unified framework, nor evaluated their translational relevance to psychiatric diagnostics. Given the limited understanding of the relationship between psychiatric disorders and ocular health, we aim to conduct a systematic review and meta-analysis to synthesize current evidence. This approach will provide a statistically rigorous assessment of the association between psychiatric disorders and ocular diseases, advancing our knowledge of these conditions and their potential shared mechanisms. Methods Study design This study is a systematic review conducted by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines [12]. The protocol was registered with the Open Science Framework (OSF) (10.17605/OSF.IO/VQU2D). The review was designed to evaluate ocular and retinal abnormalities in psychiatric disorders, integrating both structural and functional findings. Data sources and search strategy We systematically searched PubMed, Scopus, Web of Science, and Embase for studies published up until October 2025. The search strategy included controlled vocabulary (MeSH) and keywords related to psychiatric disorders (e.g., schizophrenia, bipolar disorder, dementia) and ocular pathologies (e.g., retinal abnormalities, glaucoma, contrast sensitivity, retinal nerve fiber layer thinning). A full search syntax for each database is provided in Table 1. Table 1Curated search syntaxes for each databaseDatabaseNumber of articlesSearch strategyPubMed7226➣ ("Anxiety Disorders"[Title/Abstract] OR "Anxiety Disorders"[MeSH Terms] OR "anxiety, separation"[Title/Abstract] OR "anxiety, separation"[MeSH Terms] OR "Neurocirculatory Asthenia"[Title/Abstract] OR "Neurocirculatory Asthenia"[MeSH Terms] OR "Neurotic Disorders"[Title/Abstract] OR "Neurotic Disorders"[MeSH Terms] OR "Obsessive–Compulsive Disorder"[Title/Abstract] OR "Obsessive–Compulsive Disorder"[MeSH Terms] OR "Panic Disorder"[Title/Abstract] OR "Panic Disorder"[MeSH Terms] OR "Phobic Disorders"[Title/Abstract] OR "Phobic Disorders"[MeSH Terms] OR "Feeding and Eating Disorders"[Title/Abstract] OR "Feeding and Eating Disorders"[MeSH Terms] OR "Anorexia Nervosa"[Title/Abstract] OR "Anorexia Nervosa"[MeSH Terms] OR "Avoidant Restrictive Food Intake Disorder"[Title/Abstract] OR "Avoidant Restrictive Food Intake Disorder"[MeSH Terms] OR "Binge-Eating Disorder"[Title/Abstract] OR "Binge-Eating Disorder"[MeSH Terms] OR "Bulimia Nervosa"[Title/Abstract] OR "Bulimia Nervosa"[MeSH Terms] OR "Diabulimia"[Title/Abstract] OR "Diabulimia"[MeSH Terms] OR "Feeding and Eating Disorders of Childhood"[Title/Abstract] OR "Feeding and Eating Disorders of Childhood"[MeSH Terms] OR "Food Addiction"[Title/Abstract] OR "Food Addiction"[MeSH Terms] OR "Night Eating Syndrome"[Title/Abstract] OR "Night Eating Syndrome"[MeSH Terms] OR "Orthorexia Nervosa"[Title/Abstract] OR "Orthorexia Nervosa"[MeSH Terms] OR "Pica"[Title/Abstract] OR "Pica"[MeSH Terms] OR "Relative Energy Deficiency in Sport"[Title/Abstract] OR "Relative Energy Deficiency in Sport"[MeSH Terms] OR "Rumination Syndrome"[Title/Abstract] OR "Rumination Syndrome"[MeSH Terms] OR "Neurocognitive Disorders"[Title/Abstract] OR "Neurocognitive Disorders"[MeSH Terms] OR "Amnesia"[Title/Abstract] OR "Amnesia"[MeSH Terms] OR "Cognition Disorders"[Title/Abstract] OR "Cognition Disorders"[MeSH Terms] OR "Consciousness Disorders"[Title/Abstract] OR "Consciousness Disorders"[MeSH Terms] OR "Delirium"[Title/Abstract] OR "Delirium"[MeSH Terms] OR "Dementia"[Title/Abstract] OR "Dementia"[MeSH Terms] OR "Neurotic Disorders"[Title/Abstract] OR "Neurotic Disorders"[MeSH Terms] OR "Paraphilic Disorders"[Title/Abstract] OR "Paraphilic Disorders"[MeSH Terms] OR "Exhibitionism"[Title/Abstract] OR "Exhibitionism"[MeSH Terms] OR "fetishism, psychiatric"[MeSH Terms] OR "Masochism"[Title/Abstract] OR "Masochism"[MeSH Terms] OR "Pedophilia"[Title/Abstract] OR "Pedophilia"[MeSH Terms] OR "Sadism"[Title/Abstract] OR "Sadism"[MeSH Terms] OR "Transvestism"[Title/Abstract] OR "Transvestism"[MeSH Terms] OR "Voyeurism"[Title/Abstract] OR "Voyeurism"[MeSH Terms] OR "Personality Disorders"[Title/Abstract] OR "Personality Disorders"[MeSH Terms] OR "Antisocial Personality Disorder"[Title/Abstract] OR "Antisocial Personality Disorder"[MeSH Terms] OR "Borderline Personality Disorder"[Title/Abstract] OR "Borderline Personality Disorder"[MeSH Terms] OR "Compulsive Personality Disorder"[Title/Abstract] OR "Compulsive Personality Disorder"[MeSH Terms] OR "Dependent Personality Disorder"[Title/Abstract] OR "Dependent Personality Disorder"[MeSH Terms] OR "Histrionic Personality Disorder"[Title/Abstract] OR "Histrionic Personality Disorder"[MeSH Terms] OR "Narcissistic Personality Disorder"[Title/Abstract] OR "Narcissistic Personality Disorder"[MeSH Terms] OR "Paranoid Personality Disorder"[Title/Abstract] OR "Paranoid Personality Disorder"[MeSH Terms] OR "Passive-Aggressive Personality Disorder"[Title/Abstract] OR "Passive-Aggressive Personality Disorder"[MeSH Terms] OR "Schizoid Personality Disorder"[Title/Abstract] OR "Schizoid Personality Disorder"[MeSH Terms] OR "Schizotypal Personality Disorder"[Title/Abstract] OR "Schizotypal Personality Disorder"[MeSH Terms] OR "Schizophrenia Spectrum and Other Psychotic Disorders"[Title/Abstract] OR "Schizophrenia Spectrum and Other Psychotic Disorders"[MeSH Terms] OR "affective disorders psychotic"[Title/Abstract] OR "affective disorders, psychotic"[MeSH Terms] OR "Capgras Syndrome"[Title/Abstract] OR "Capgras Syndrome"[MeSH Terms] OR "Delusional Parasitosis"[Title/Abstract] OR "Delusional Parasitosis"[MeSH Terms] OR "Morgellons Disease"[Title/Abstract] OR "Morgellons Disease"[MeSH Terms] OR "Paranoid Disorders"[Title/Abstract] OR "Paranoid Disorders"[MeSH Terms] OR "Psychotic Disorders"[Title/Abstract] OR "Psychotic Disorders"[MeSH Terms] OR "Schizophrenia"[Title/Abstract] OR "Schizophrenia"[MeSH Terms]) AND ("Ocular pathologies"[Title/Abstract] OR "ocular disorders"[Title/Abstract] OR "ocular diseases"[Title/Abstract] OR "ocular illnesses"[Title/Abstract] OR "eye disorders"[Title/Abstract] OR "Eye Diseases"[Title/Abstract] OR "eye illnesses"[Title/Abstract] OR "retinal diseases"[Title/Abstract] OR "Eye Diseases"[MeSH Terms] OR "Vision Disorders"[Title/Abstract] OR "Vision Disorders"[MeSH Terms] OR "Eye Manifestations"[Title/Abstract] OR "Eye Manifestations"[MeSH Terms] OR "Optic Nerve Diseases"[Title/Abstract] OR "Optic Nerve Diseases"[MeSH Terms] OR "eye diseases hereditary"[Title/Abstract] OR "eye diseases, hereditary"[MeSH Terms])WOS164• 1) (((((((((((TS = ("Ocular pathologies")) OR TS = ("ocular disorders")) OR TS = ("ocular diseases")) OR TS = ("ocular illnesses")) OR TS = ("eye disorders")) OR TS = ("eye diseases")) OR TS = ("eye illnesses")) OR TS = ("retinal diseases")) OR TS = ("Vision Disorders")) OR TS = ("Eye Manifestations")) OR TS = ("Optic Nerve Diseases")) OR TS = ("Eye Diseases, Hereditary")• 2) ((((((((((((((((((((((((((((((((((((((((((((((((((((((TS = ("Anxiety Disorders")) OR TS = ("Anxiety, Separation")) OR TS = ("Neurocirculatory Asthenia")) OR TS = ("Neurotic Disorders")) OR TS = ("Obsessive–Compulsive Disorder")) OR TS = ("Panic Disorder")) OR TS = ("Phobic Disorders")) OR TS = ("Feeding and Eating Disorders")) OR TS = ("Anorexia Nervosa")) OR TS = ("Avoidant Restrictive Food Intake Disorder")) OR TS = ("Binge-Eating Disorder")) OR TS = ("Bulimia Nervosa")) OR TS = (Diabulimia)) OR TS = ("Feeding and Eating Disorders of Childhood")) OR TS = ("Food Addiction")) OR TS = ("Night Eating Syndrome")) OR TS = ("Orthorexia Nervosa")) OR TS = (Pica)) OR TS = ("Relative Energy Deficiency in Sport")) OR TS = ("Rumination Syndrome")) OR TS = ("Neurocognitive Disorders")) OR TS = (Amnesia)) OR TS = ("Cognition Disorders")) OR TS = ("Consciousness Disorders")) OR TS = (Delirium)) OR TS = (Dementia)) OR TS = ("Neurotic Disorders")) OR TS = ("Paraphilic Disorders")) OR TS = (Exhibitionism)) OR TS = ("Fetishism, Psychiatric")) OR TS = (Masochism)) OR TS = (Pedophilia)) OR TS = (Sadism)) OR TS = (Transvestism)) OR TS = (Voyeurism)) OR TS = ("Personality Disorders")) OR TS = ("Antisocial Personality Disorder")) OR TS = ("Borderline Personality Disorder")) OR TS = ("Compulsive Personality Disorder")) OR TS = ("Dependent Personality Disorder")) OR TS = ("Histrionic Personality Disorder")) OR TS = ("Narcissistic Personality Disorder")) OR TS = ("Paranoid Personality Disorder")) OR TS = ("Passive-Aggressive Personality Disorder")) OR TS = ("Schizoid Personality Disorder")) OR TS = ("Schizotypal Personality Disorder")) OR TS = ("Schizophrenia Spectrum and Other Psychotic Disorders")) OR TS = ("Affective Disorders, Psychotic")) OR TS = ("Capgras Syndrome")) OR TS = ("Delusional Parasitosis")) OR TS = ("Morgellons Disease")) OR TS = ("Paranoid Disorders")) OR TS = ("Psychotic Disorders")) OR TS = (Schizophrenia)Scopus2828➣ (TITLE-ABS-KEY ("Ocular pathologies") OR TITLE-ABS-KEY ("ocular disorders") OR TITLE-ABS-KEY ("ocular diseases") OR TITLE-ABS-KEY ("ocular illnesses") OR TITLE-ABS-KEY ("eye disorders") OR TITLE-ABS-KEY ("eye diseases") OR TITLE-ABS-KEY ("eye illnesses") OR TITLE-ABS-KEY ("retinal diseases") OR TITLE-ABS-KEY ("Vision Disorders") OR TITLE-ABS-KEY ("Eye Manifestations") OR TITLE-ABS-KEY ("Optic Nerve Diseases") OR TITLE-ABS-KEY ("Eye Diseases, Hereditary")) AND (TITLE-ABS-KEY ("Anxiety Disorders") OR TITLE-ABS-KEY ("Anxiety, Separation") OR TITLE-ABS-KEY ("Neurocirculatory Asthenia") OR TITLE-ABS-KEY ("Neurotic Disorders") OR TITLE-ABS-KEY ("Obsessive–Compulsive Disorder") OR TITLE-ABS-KEY ("Panic Disorder") OR TITLE-ABS-KEY ("Phobic Disorders") OR TITLE-ABS-KEY ("Feeding and Eating Disorders") OR TITLE-ABS-KEY ("Anorexia Nervosa") OR TITLE-ABS-KEY ("Avoidant Restrictive Food Intake Disorder") OR TITLE-ABS-KEY ("Binge-Eating Disorder") OR TITLE-ABS-KEY ("Bulimia Nervosa") OR TITLE-ABS-KEY (diabulimia) OR TITLE-ABS-KEY ("Feeding and Eating Disorders of Childhood") OR TITLE-ABS-KEY ("Food Addiction") OR TITLE-ABS-KEY ("Night Eating Syndrome") OR TITLE-ABS-KEY ("Orthorexia Nervosa") OR TITLE-ABS-KEY (pica) OR TITLE-ABS-KEY ("Relative Energy Deficiency in Sport") OR TITLE-ABS-KEY ("Rumination Syndrome") OR TITLE-ABS-KEY ("Neurocognitive Disorders") OR TITLE-ABS-KEY (amnesia) OR TITLE-ABS-KEY ("Cognition Disorders") OR TITLE-ABS-KEY ("Consciousness Disorders") OR TITLE-ABS-KEY (delirium) OR TITLE-ABS-KEY (dementia) OR TITLE-ABS-KEY ("Neurotic Disorders") OR TITLE-ABS-KEY ("Paraphilic Disorders") OR TITLE-ABS-KEY (exhibitionism) OR TITLE-ABS-KEY ("Fetishism, Psychiatric") OR TITLE-ABS-KEY (masochism) OR TITLE-ABS-KEY (pedophilia) OR TITLE-ABS-KEY (sadism) OR TITLE-ABS-KEY (transvestism) OR TITLE-ABS-KEY (voyeurism) OR TITLE-ABS-KEY ("Personality Disorders") OR TITLE-ABS-KEY ("Antisocial Personality Disorder") OR TITLE-ABS-KEY ("Borderline Personality Disorder") OR TITLE-ABS-KEY ("Compulsive Personality Disorder") OR TITLE-ABS-KEY ("Dependent Personality Disorder") OR TITLE-ABS-KEY ("Histrionic Personality Disorder") OR TITLE-ABS-KEY ("Narcissistic Personality Disorder") OR TITLE-ABS-KEY ("Paranoid Personality Disorder") OR TITLE-ABS-KEY ("Passive-Aggressive Personality Disorder") OR TITLE-ABS-KEY ("Schizoid Personality Disorder") OR TITLE-ABS-KEY ("Schizotypal Personality Disorder") OR TITLE-ABS-KEY ("Schizophrenia Spectrum and Other Psychotic Disorders") OR TITLE-ABS-KEY ("Affective Disorders, Psychotic") OR TITLE-ABS-KEY ("Capgras Syndrome") OR TITLE-ABS-KEY ("Delusional Parasitosis") OR TITLE-ABS-KEY ("Morgellons Disease") OR TITLE-ABS-KEY ("Paranoid Disorders") OR TITLE-ABS-KEY ("Psychotic Disorders") OR TITLE-ABS-KEY (schizophrenia)) Table 1Curated search syntaxes for each databaseDatabaseNumber of articlesSearch strategyPubMed7226➣ ("Anxiety Disorders"[Title/Abstract] OR "Anxiety Disorders"[MeSH Terms] OR "anxiety, separation"[Title/Abstract] OR "anxiety, separation"[MeSH Terms] OR "Neurocirculatory Asthenia"[Title/Abstract] OR "Neurocirculatory Asthenia"[MeSH Terms] OR "Neurotic Disorders"[Title/Abstract] OR "Neurotic Disorders"[MeSH Terms] OR "Obsessive–Compulsive Disorder"[Title/Abstract] OR "Obsessive–Compulsive Disorder"[MeSH Terms] OR "Panic Disorder"[Title/Abstract] OR "Panic Disorder"[MeSH Terms] OR "Phobic Disorders"[Title/Abstract] OR "Phobic Disorders"[MeSH Terms] OR "Feeding and Eating Disorders"[Title/Abstract] OR "Feeding and Eating Disorders"[MeSH Terms] OR "Anorexia Nervosa"[Title/Abstract] OR "Anorexia Nervosa"[MeSH Terms] OR "Avoidant Restrictive Food Intake Disorder"[Title/Abstract] OR "Avoidant Restrictive Food Intake Disorder"[MeSH Terms] OR "Binge-Eating Disorder"[Title/Abstract] OR "Binge-Eating Disorder"[MeSH Terms] OR "Bulimia Nervosa"[Title/Abstract] OR "Bulimia Nervosa"[MeSH Terms] OR "Diabulimia"[Title/Abstract] OR "Diabulimia"[MeSH Terms] OR "Feeding and Eating Disorders of Childhood"[Title/Abstract] OR "Feeding and Eating Disorders of Childhood"[MeSH Terms] OR "Food Addiction"[Title/Abstract] OR "Food Addiction"[MeSH Terms] OR "Night Eating Syndrome"[Title/Abstract] OR "Night Eating Syndrome"[MeSH Terms] OR "Orthorexia Nervosa"[Title/Abstract] OR "Orthorexia Nervosa"[MeSH Terms] OR "Pica"[Title/Abstract] OR "Pica"[MeSH Terms] OR "Relative Energy Deficiency in Sport"[Title/Abstract] OR "Relative Energy Deficiency in Sport"[MeSH Terms] OR "Rumination Syndrome"[Title/Abstract] OR "Rumination Syndrome"[MeSH Terms] OR "Neurocognitive Disorders"[Title/Abstract] OR "Neurocognitive Disorders"[MeSH Terms] OR "Amnesia"[Title/Abstract] OR "Amnesia"[MeSH Terms] OR "Cognition Disorders"[Title/Abstract] OR "Cognition Disorders"[MeSH Terms] OR "Consciousness Disorders"[Title/Abstract] OR "Consciousness Disorders"[MeSH Terms] OR "Delirium"[Title/Abstract] OR "Delirium"[MeSH Terms] OR "Dementia"[Title/Abstract] OR "Dementia"[MeSH Terms] OR "Neurotic Disorders"[Title/Abstract] OR "Neurotic Disorders"[MeSH Terms] OR "Paraphilic Disorders"[Title/Abstract] OR "Paraphilic Disorders"[MeSH Terms] OR "Exhibitionism"[Title/Abstract] OR "Exhibitionism"[MeSH Terms] OR "fetishism, psychiatric"[MeSH Terms] OR "Masochism"[Title/Abstract] OR "Masochism"[MeSH Terms] OR "Pedophilia"[Title/Abstract] OR "Pedophilia"[MeSH Terms] OR "Sadism"[Title/Abstract] OR "Sadism"[MeSH Terms] OR "Transvestism"[Title/Abstract] OR "Transvestism"[MeSH Terms] OR "Voyeurism"[Title/Abstract] OR "Voyeurism"[MeSH Terms] OR "Personality Disorders"[Title/Abstract] OR "Personality Disorders"[MeSH Terms] OR "Antisocial Personality Disorder"[Title/Abstract] OR "Antisocial Personality Disorder"[MeSH Terms] OR "Borderline Personality Disorder"[Title/Abstract] OR "Borderline Personality Disorder"[MeSH Terms] OR "Compulsive Personality Disorder"[Title/Abstract] OR "Compulsive Personality Disorder"[MeSH Terms] OR "Dependent Personality Disorder"[Title/Abstract] OR "Dependent Personality Disorder"[MeSH Terms] OR "Histrionic Personality Disorder"[Title/Abstract] OR "Histrionic Personality Disorder"[MeSH Terms] OR "Narcissistic Personality Disorder"[Title/Abstract] OR "Narcissistic Personality Disorder"[MeSH Terms] OR "Paranoid Personality Disorder"[Title/Abstract] OR "Paranoid Personality Disorder"[MeSH Terms] OR "Passive-Aggressive Personality Disorder"[Title/Abstract] OR "Passive-Aggressive Personality Disorder"[MeSH Terms] OR "Schizoid Personality Disorder"[Title/Abstract] OR "Schizoid Personality Disorder"[MeSH Terms] OR "Schizotypal Personality Disorder"[Title/Abstract] OR "Schizotypal Personality Disorder"[MeSH Terms] OR "Schizophrenia Spectrum and Other Psychotic Disorders"[Title/Abstract] OR "Schizophrenia Spectrum and Other Psychotic Disorders"[MeSH Terms] OR "affective disorders psychotic"[Title/Abstract] OR "affective disorders, psychotic"[MeSH Terms] OR "Capgras Syndrome"[Title/Abstract] OR "Capgras Syndrome"[MeSH Terms] OR "Delusional Parasitosis"[Title/Abstract] OR "Delusional Parasitosis"[MeSH Terms] OR "Morgellons Disease"[Title/Abstract] OR "Morgellons Disease"[MeSH Terms] OR "Paranoid Disorders"[Title/Abstract] OR "Paranoid Disorders"[MeSH Terms] OR "Psychotic Disorders"[Title/Abstract] OR "Psychotic Disorders"[MeSH Terms] OR "Schizophrenia"[Title/Abstract] OR "Schizophrenia"[MeSH Terms]) AND ("Ocular pathologies"[Title/Abstract] OR "ocular disorders"[Title/Abstract] OR "ocular diseases"[Title/Abstract] OR "ocular illnesses"[Title/Abstract] OR "eye disorders"[Title/Abstract] OR "Eye Diseases"[Title/Abstract] OR "eye illnesses"[Title/Abstract] OR "retinal diseases"[Title/Abstract] OR "Eye Diseases"[MeSH Terms] OR "Vision Disorders"[Title/Abstract] OR "Vision Disorders"[MeSH Terms] OR "Eye Manifestations"[Title/Abstract] OR "Eye Manifestations"[MeSH Terms] OR "Optic Nerve Diseases"[Title/Abstract] OR "Optic Nerve Diseases"[MeSH Terms] OR "eye diseases hereditary"[Title/Abstract] OR "eye diseases, hereditary"[MeSH Terms])WOS164• 1) (((((((((((TS = ("Ocular pathologies")) OR TS = ("ocular disorders")) OR TS = ("ocular diseases")) OR TS = ("ocular illnesses")) OR TS = ("eye disorders")) OR TS = ("eye diseases")) OR TS = ("eye illnesses")) OR TS = ("retinal diseases")) OR TS = ("Vision Disorders")) OR TS = ("Eye Manifestations")) OR TS = ("Optic Nerve Diseases")) OR TS = ("Eye Diseases, Hereditary")• 2) ((((((((((((((((((((((((((((((((((((((((((((((((((((((TS = ("Anxiety Disorders")) OR TS = ("Anxiety, Separation")) OR TS = ("Neurocirculatory Asthenia")) OR TS = ("Neurotic Disorders")) OR TS = ("Obsessive–Compulsive Disorder")) OR TS = ("Panic Disorder")) OR TS = ("Phobic Disorders")) OR TS = ("Feeding and Eating Disorders")) OR TS = ("Anorexia Nervosa")) OR TS = ("Avoidant Restrictive Food Intake Disorder")) OR TS = ("Binge-Eating Disorder")) OR TS = ("Bulimia Nervosa")) OR TS = (Diabulimia)) OR TS = ("Feeding and Eating Disorders of Childhood")) OR TS = ("Food Addiction")) OR TS = ("Night Eating Syndrome")) OR TS = ("Orthorexia Nervosa")) OR TS = (Pica)) OR TS = ("Relative Energy Deficiency in Sport")) OR TS = ("Rumination Syndrome")) OR TS = ("Neurocognitive Disorders")) OR TS = (Amnesia)) OR TS = ("Cognition Disorders")) OR TS = ("Consciousness Disorders")) OR TS = (Delirium)) OR TS = (Dementia)) OR TS = ("Neurotic Disorders")) OR TS = ("Paraphilic Disorders")) OR TS = (Exhibitionism)) OR TS = ("Fetishism, Psychiatric")) OR TS = (Masochism)) OR TS = (Pedophilia)) OR TS = (Sadism)) OR TS = (Transvestism)) OR TS = (Voyeurism)) OR TS = ("Personality Disorders")) OR TS = ("Antisocial Personality Disorder")) OR TS = ("Borderline Personality Disorder")) OR TS = ("Compulsive Personality Disorder")) OR TS = ("Dependent Personality Disorder")) OR TS = ("Histrionic Personality Disorder")) OR TS = ("Narcissistic Personality Disorder")) OR TS = ("Paranoid Personality Disorder")) OR TS = ("Passive-Aggressive Personality Disorder")) OR TS = ("Schizoid Personality Disorder")) OR TS = ("Schizotypal Personality Disorder")) OR TS = ("Schizophrenia Spectrum and Other Psychotic Disorders")) OR TS = ("Affective Disorders, Psychotic")) OR TS = ("Capgras Syndrome")) OR TS = ("Delusional Parasitosis")) OR TS = ("Morgellons Disease")) OR TS = ("Paranoid Disorders")) OR TS = ("Psychotic Disorders")) OR TS = (Schizophrenia)Scopus2828➣ (TITLE-ABS-KEY ("Ocular pathologies") OR TITLE-ABS-KEY ("ocular disorders") OR TITLE-ABS-KEY ("ocular diseases") OR TITLE-ABS-KEY ("ocular illnesses") OR TITLE-ABS-KEY ("eye disorders") OR TITLE-ABS-KEY ("eye diseases") OR TITLE-ABS-KEY ("eye illnesses") OR TITLE-ABS-KEY ("retinal diseases") OR TITLE-ABS-KEY ("Vision Disorders") OR TITLE-ABS-KEY ("Eye Manifestations") OR TITLE-ABS-KEY ("Optic Nerve Diseases") OR TITLE-ABS-KEY ("Eye Diseases, Hereditary")) AND (TITLE-ABS-KEY ("Anxiety Disorders") OR TITLE-ABS-KEY ("Anxiety, Separation") OR TITLE-ABS-KEY ("Neurocirculatory Asthenia") OR TITLE-ABS-KEY ("Neurotic Disorders") OR TITLE-ABS-KEY ("Obsessive–Compulsive Disorder") OR TITLE-ABS-KEY ("Panic Disorder") OR TITLE-ABS-KEY ("Phobic Disorders") OR TITLE-ABS-KEY ("Feeding and Eating Disorders") OR TITLE-ABS-KEY ("Anorexia Nervosa") OR TITLE-ABS-KEY ("Avoidant Restrictive Food Intake Disorder") OR TITLE-ABS-KEY ("Binge-Eating Disorder") OR TITLE-ABS-KEY ("Bulimia Nervosa") OR TITLE-ABS-KEY (diabulimia) OR TITLE-ABS-KEY ("Feeding and Eating Disorders of Childhood") OR TITLE-ABS-KEY ("Food Addiction") OR TITLE-ABS-KEY ("Night Eating Syndrome") OR TITLE-ABS-KEY ("Orthorexia Nervosa") OR TITLE-ABS-KEY (pica) OR TITLE-ABS-KEY ("Relative Energy Deficiency in Sport") OR TITLE-ABS-KEY ("Rumination Syndrome") OR TITLE-ABS-KEY ("Neurocognitive Disorders") OR TITLE-ABS-KEY (amnesia) OR TITLE-ABS-KEY ("Cognition Disorders") OR TITLE-ABS-KEY ("Consciousness Disorders") OR TITLE-ABS-KEY (delirium) OR TITLE-ABS-KEY (dementia) OR TITLE-ABS-KEY ("Neurotic Disorders") OR TITLE-ABS-KEY ("Paraphilic Disorders") OR TITLE-ABS-KEY (exhibitionism) OR TITLE-ABS-KEY ("Fetishism, Psychiatric") OR TITLE-ABS-KEY (masochism) OR TITLE-ABS-KEY (pedophilia) OR TITLE-ABS-KEY (sadism) OR TITLE-ABS-KEY (transvestism) OR TITLE-ABS-KEY (voyeurism) OR TITLE-ABS-KEY ("Personality Disorders") OR TITLE-ABS-KEY ("Antisocial Personality Disorder") OR TITLE-ABS-KEY ("Borderline Personality Disorder") OR TITLE-ABS-KEY ("Compulsive Personality Disorder") OR TITLE-ABS-KEY ("Dependent Personality Disorder") OR TITLE-ABS-KEY ("Histrionic Personality Disorder") OR TITLE-ABS-KEY ("Narcissistic Personality Disorder") OR TITLE-ABS-KEY ("Paranoid Personality Disorder") OR TITLE-ABS-KEY ("Passive-Aggressive Personality Disorder") OR TITLE-ABS-KEY ("Schizoid Personality Disorder") OR TITLE-ABS-KEY ("Schizotypal Personality Disorder") OR TITLE-ABS-KEY ("Schizophrenia Spectrum and Other Psychotic Disorders") OR TITLE-ABS-KEY ("Affective Disorders, Psychotic") OR TITLE-ABS-KEY ("Capgras Syndrome") OR TITLE-ABS-KEY ("Delusional Parasitosis") OR TITLE-ABS-KEY ("Morgellons Disease") OR TITLE-ABS-KEY ("Paranoid Disorders") OR TITLE-ABS-KEY ("Psychotic Disorders") OR TITLE-ABS-KEY (schizophrenia)) Curated search syntaxes for each database • 1) (((((((((((TS = ("Ocular pathologies")) OR TS = ("ocular disorders")) OR TS = ("ocular diseases")) OR TS = ("ocular illnesses")) OR TS = ("eye disorders")) OR TS = ("eye diseases")) OR TS = ("eye illnesses")) OR TS = ("retinal diseases")) OR TS = ("Vision Disorders")) OR TS = ("Eye Manifestations")) OR TS = ("Optic Nerve Diseases")) OR TS = ("Eye Diseases, Hereditary") • 2) ((((((((((((((((((((((((((((((((((((((((((((((((((((((TS = ("Anxiety Disorders")) OR TS = ("Anxiety, Separation")) OR TS = ("Neurocirculatory Asthenia")) OR TS = ("Neurotic Disorders")) OR TS = ("Obsessive–Compulsive Disorder")) OR TS = ("Panic Disorder")) OR TS = ("Phobic Disorders")) OR TS = ("Feeding and Eating Disorders")) OR TS = ("Anorexia Nervosa")) OR TS = ("Avoidant Restrictive Food Intake Disorder")) OR TS = ("Binge-Eating Disorder")) OR TS = ("Bulimia Nervosa")) OR TS = (Diabulimia)) OR TS = ("Feeding and Eating Disorders of Childhood")) OR TS = ("Food Addiction")) OR TS = ("Night Eating Syndrome")) OR TS = ("Orthorexia Nervosa")) OR TS = (Pica)) OR TS = ("Relative Energy Deficiency in Sport")) OR TS = ("Rumination Syndrome")) OR TS = ("Neurocognitive Disorders")) OR TS = (Amnesia)) OR TS = ("Cognition Disorders")) OR TS = ("Consciousness Disorders")) OR TS = (Delirium)) OR TS = (Dementia)) OR TS = ("Neurotic Disorders")) OR TS = ("Paraphilic Disorders")) OR TS = (Exhibitionism)) OR TS = ("Fetishism, Psychiatric")) OR TS = (Masochism)) OR TS = (Pedophilia)) OR TS = (Sadism)) OR TS = (Transvestism)) OR TS = (Voyeurism)) OR TS = ("Personality Disorders")) OR TS = ("Antisocial Personality Disorder")) OR TS = ("Borderline Personality Disorder")) OR TS = ("Compulsive Personality Disorder")) OR TS = ("Dependent Personality Disorder")) OR TS = ("Histrionic Personality Disorder")) OR TS = ("Narcissistic Personality Disorder")) OR TS = ("Paranoid Personality Disorder")) OR TS = ("Passive-Aggressive Personality Disorder")) OR TS = ("Schizoid Personality Disorder")) OR TS = ("Schizotypal Personality Disorder")) OR TS = ("Schizophrenia Spectrum and Other Psychotic Disorders")) OR TS = ("Affective Disorders, Psychotic")) OR TS = ("Capgras Syndrome")) OR TS = ("Delusional Parasitosis")) OR TS = ("Morgellons Disease")) OR TS = ("Paranoid Disorders")) OR TS = ("Psychotic Disorders")) OR TS = (Schizophrenia) Eligibility criteria Studies were included if they met the following criteria: Original research articles involving human subjects. Assessed ocular pathologies in the context of diagnosed psychiatric disorders. Published in English. Provided either qualitative or quantitative data linking psychiatric and ocular outcomes. Exclusion criteria included case reports, animal studies, reviews, and studies with insufficient clinical detail or unrelated outcomes. Study selection and data extraction Titles and abstracts were independently screened by two reviewers (FNF and MM), followed by a full-text evaluation of eligible studies. Discrepancies were resolved through discussion with a third reviewer (MAA). Data were extracted into a standardized form, capturing: Author, year, country. Psychiatric diagnosis. Ocular outcomes assessed. Retinal imaging modality (if applicable). Study design and sample characteristics. Detailed study-level data are presented in Table 1. Quality assessment Methodological quality was evaluated using the Joanna Briggs Institute (JBI) Critical Appraisal Tools, specifically tailored to the study design (cross-sectional or cohort). Risk of bias was assessed independently by two reviewers, with consensus adjudication as needed. The quality assessment table has been demonstrated in supplementary Table 1. Systematic synthesis and visualization Quantitative pooling was not feasible due to substantial heterogeneity in study designs, participant characteristics, diagnostic frameworks, ocular outcome measures, and imaging modalities. These variations precluded the reliable computation of pooled estimates and would have risked introducing bias or misleading inferences. Therefore, a structured narrative synthesis was undertaken, grouping studies by psychiatric diagnosis and retinal or visual domain. For visual summarization, a Disorder-to-Ocular Pathology Heatmap was created using Python’s seaborn library (v0.13). Each cell represented the presence (1) or absence (0) of a reported association, determined by whether the original study documented a statistically significant difference (p < 0.05) or a consistent abnormality compared to controls. A complementary Retinal Biomarker Summary Chart visualized recurring patterns such as retinal nerve fiber layer (RNFL) thinning and OCT-A-based microvascular dropout across disorders. These visualization tools served to qualitatively map evidence rather than to perform inferential statistics. Result Study selection A total of 10,218 records were identified through database searches. After removing duplicates, 4,852 unique records were screened by title and abstract, and 1,591 full-texts were assessed for eligibility. Ultimately, 17 studies met all inclusion criteria and were included in the qualitative synthesis (Fig. 1, PRISMA flow diagram).Fig.1PRISMA flow diagram of included studies PRISMA flow diagram of included studies The relatively small number of included studies, despite a large number of full-texts reviewed, reflects the strict eligibility criteria applied, particularly the requirement for clearly diagnosed psychiatric disorders and objectively measured ocular or retinal outcomes. Many studies were excluded for lacking standardized diagnostic assessments, incomplete ocular data, or confounding systemic pathologies, which underscores the methodological scarcity in this emerging field. Study characteristics The included studies spanned multiple countries, including the United States, Brazil, Germany, Taiwan, China, and Austria, with varied sample sizes and study designs (predominantly cross-sectional and case–control). To provide a quantitative sense of distribution without implying meta-analytic precision, approximately three-quarters of schizophrenia studies (≈75%) reported retinal nerve fiber layer (RNFL) thinning, while over half of dementia studies (≈67%) observed retinal vascular abnormalities or RNFL loss. In mood disorders, glaucoma and dry eye syndrome were the most frequently reported findings, whereas retinal microvascular dropout was highlighted in optical coherence tomography angiography (OCT-A) analyses of depression and bipolar disorder. These patterns suggest partial overlaps between neurodevelopmental and neurodegenerative ocular signatures. Key characteristics and findings are summarized in Table 2. Table 2Summary characteristics of included studiesAuthorYearType of vision impairmentPsychiatric disorderKey findingsAlmeida NL et al2020Visual processing impairments (contrast sensitivity function)SchizophreniaThe mechanism linking medication adverse effects and illness duration to visual processing impairments remains unclearAvsar KB et al2011Visual perception (aberrant visual circuitry)SchizophreniaPatients with schizophrenia showed reduced activation in frontal–striatal–thalamic and occipital–temporal cortical networks compared to controls, despite normal spatial match-to-sample accuracy. The striate cortex and corticocortical pathways are critical for visual recognitionChen YC et al2011Smooth pursuit eye movement (SPEM)SchizophreniaConfirmatory factor analysis and structural equation modeling of SPEM and Wisconsin Card Sorting Test measures showed good content validity and discrimination, suggesting potential as clinical markers for subtyping schizophrenia and predicting its courseDahdouh O et al2020Color vision defectSchizophreniaColor vision deficits may relate to P pathway deficits and dopaminergic system dysfunction. No correlation was found with positive or negative symptoms, but overall and cognitive symptom severity correlated with color blindness, possibly influenced by antipsychoticsFabisch K et al2009Eye-tracking dysfunction (position and velocity error processing)SchizophreniaPosition error was more pronounced than velocity error, suggesting distinct neuronal systems for processing. The middle temporal area may handle velocity, while the superior colliculus processes position informationGonzález-Hernández JA et al2014Basic visual dysfunctionSchizophreniaMultiple visual generator deficits (P1 and N1 components) in areas like medial occipital–temporal, parahippocampus, and posterior cingulum suggest a basic visual dysfunction contributing to cognitive and visual aberrations, with symptom severity linked to specific neural deficitsGrove T et al2018Impaired visual integrationSchizophreniaDeficient early visual processing in schizophrenia may underlie visual integration deficits. Cognitive remediation and transcranial direct-current stimulation could improve occipital cortical function and higher-order cognition in psychosisHong LE et al2009Motion perception deficit/eye tracking abnormalitySchizophreniaMotion perception deficits in schizophrenia may stem from impaired integration of SPEM-induced extraretinal motion signals. No group differences in speed discrimination when eye movements were limited, suggesting fixation effectsLatham C et al1981Optokinetic nystagmus and pursuit eye movementsSchizophreniaImpaired pursuit eye movements suggest cortical dysfunction, likely in the parietal association cortex, rather than brainstem involvement, as other oculomotor functions remain intactLe et al2022Late age-related macular degeneration (AMD)Cognitive impairmentAMD and Alzheimer’s disease share pathophysiological processes, including amyloid-β accumulation, oxidative stress, and inflammation, suggesting a bidirectional relationship that warrants further explorationLee ATC et al2020Poor visual acuityCognitive impairment/dementiaPoor visual acuity may reduce visual input, weakening neuronal networks supporting cognitive processes, though underlying mechanisms require further studyLencer R et al2003Eye-tracking dysfunctionSchizophreniaEye-tracking dysfunction may result from motion perception deficits involving cortical areas (V5, frontal eye field) and extraretinal mechanisms. Weak correlations with neuropsychological deficits suggest shared pathways with sensory gating and deficit syndromeLi W et al2015Abnormalities in processing visual informationAnorexia nervosa (AN), body dysmorphic disorder (BDD)AN and BDD show hypoactivity in dorsal visual stream for low spatial frequencies, indicating deficits in holistic processing. BDD shows hyperactivity for high spatial frequency houses, suggesting magnocellular pathway deficits contributing to distorted perceptionsLittlejohns TJ et al2022Visual impairment/visual acuityDementiaImpaired visual processing may directly affect cognition through sensory deprivation or information degradation. Retinal nerve fiber layer thinning, abnormal pupillary response, and contrast sensitivity are proposed dementia biomarkersLiu Y et al2020Ocular neurovascular diseases (AMD, central serous retinopathy, retinal vascular occlusion, diabetic retinopathy, glaucoma, dry eye syndrome, optic neuropathy)Schizophrenia, bipolar disorder, major depressive disorderGlaucoma’s link to psychiatric disorders may involve shared pathophysiology, with closed-angle glaucoma tied to structural abnormalities and open-angle glaucoma to neural processes, requiring further mechanistic investigationLiu Y et al2015Retinal nerve fiber layer (RNFL) thickness changesMild cognitive impairment, Alzheimer’s diseaseRNFL thinning in superior and inferior quadrants correlates with Alzheimer’s disease progression and amyloid-β accumulation. Mild cognitive impairment shows similar RNFL changes, suggesting early visual pathway involvementMakin SM et al2013Complex visual hallucinations (CVH) and attentional performanceDementia, eye diseaseVisual hallucinations in dementia are linked to impaired visual attention and perception, but not in eye disease, suggesting different or dynamic mechanisms despite similar hallucination contentMandas A et al2014Age-related vision disorders (macular degeneration)Mild cognitive impairment, mixed dementia, vascular dementia, Alzheimer’s diseaseMacular degeneration and dementia share nerve cell loss and neurodegenerative pathophysiology, with associations more evident in older populationsMeyhofer I et al2015Deficits in smooth-pursuit eye movements (SPEM)SchizotypyHigh schizotypy groups show lower BOLD signals in occipital regions (V5, fusiform gyrus, V3A) during SPEM, indicating motion perception deficits. Protective factors like increased prefrontal cortical thickness may reduce schizophrenia riskMitropoulou V et al2011Eye-tracking impairmentSchizophrenia, schizotypal personality disorderSchizophrenia patients show greater eye tracking impairment than controls and relatives, with schizotypal personality disorder intermediate. Differences are unrelated to age or symptomatology, possibly due to task velocity or genetic factorsMoore P et al2016Neuromyelitis opticaCognitive impairmentsCognitive impairment in neuromyelitis optica is associated with neurological disability but not disease duration, highlighting the need to study depression and cognitive comorbidities for early interventionMoretti R et al2020Visual hallucinations, ocular pathologies (glaucoma, macular degeneration, hypertensive/diabetic retinal complications)Subcortical vascular dementiaOcular pathologies in subcortical vascular dementia are linked to worse functional outcomes and reduced apathy compared to those without ocular issues, with white matter rarefactions associated with hallucinationsMoschos MM et al2011Anatomical/functional impairment of retina and optic nerve, macular/RNFL thicknessAnorexia nervosa (AN)AN patients show decreased macular and RNFL thickness, possibly due to impaired dopaminergic neurotransmission rather than vitamin A deficiency, with greater foveal impairment in the binge–purge subtypeMurgatroyd C et al2001Visual hallucinosis and visual sensory statusDementiaVisual hallucinosis is associated with poorer visual acuity and performance on clock drawing/object recognition tests, suggesting low vision as a contributing factor to disturbed behaviorNam GE et al2021Retinal vein occlusionDementiaRetinal vein occlusion is associated with Alzheimer’s disease risk, linked to reduced macular blood flow, sparser microvascular networks, and cerebral small vessel disease, particularly in hypertensive individuals Table 2Summary characteristics of included studiesAuthorYearType of vision impairmentPsychiatric disorderKey findingsAlmeida NL et al2020Visual processing impairments (contrast sensitivity function)SchizophreniaThe mechanism linking medication adverse effects and illness duration to visual processing impairments remains unclearAvsar KB et al2011Visual perception (aberrant visual circuitry)SchizophreniaPatients with schizophrenia showed reduced activation in frontal–striatal–thalamic and occipital–temporal cortical networks compared to controls, despite normal spatial match-to-sample accuracy. The striate cortex and corticocortical pathways are critical for visual recognitionChen YC et al2011Smooth pursuit eye movement (SPEM)SchizophreniaConfirmatory factor analysis and structural equation modeling of SPEM and Wisconsin Card Sorting Test measures showed good content validity and discrimination, suggesting potential as clinical markers for subtyping schizophrenia and predicting its courseDahdouh O et al2020Color vision defectSchizophreniaColor vision deficits may relate to P pathway deficits and dopaminergic system dysfunction. No correlation was found with positive or negative symptoms, but overall and cognitive symptom severity correlated with color blindness, possibly influenced by antipsychoticsFabisch K et al2009Eye-tracking dysfunction (position and velocity error processing)SchizophreniaPosition error was more pronounced than velocity error, suggesting distinct neuronal systems for processing. The middle temporal area may handle velocity, while the superior colliculus processes position informationGonzález-Hernández JA et al2014Basic visual dysfunctionSchizophreniaMultiple visual generator deficits (P1 and N1 components) in areas like medial occipital–temporal, parahippocampus, and posterior cingulum suggest a basic visual dysfunction contributing to cognitive and visual aberrations, with symptom severity linked to specific neural deficitsGrove T et al2018Impaired visual integrationSchizophreniaDeficient early visual processing in schizophrenia may underlie visual integration deficits. Cognitive remediation and transcranial direct-current stimulation could improve occipital cortical function and higher-order cognition in psychosisHong LE et al2009Motion perception deficit/eye tracking abnormalitySchizophreniaMotion perception deficits in schizophrenia may stem from impaired integration of SPEM-induced extraretinal motion signals. No group differences in speed discrimination when eye movements were limited, suggesting fixation effectsLatham C et al1981Optokinetic nystagmus and pursuit eye movementsSchizophreniaImpaired pursuit eye movements suggest cortical dysfunction, likely in the parietal association cortex, rather than brainstem involvement, as other oculomotor functions remain intactLe et al2022Late age-related macular degeneration (AMD)Cognitive impairmentAMD and Alzheimer’s disease share pathophysiological processes, including amyloid-β accumulation, oxidative stress, and inflammation, suggesting a bidirectional relationship that warrants further explorationLee ATC et al2020Poor visual acuityCognitive impairment/dementiaPoor visual acuity may reduce visual input, weakening neuronal networks supporting cognitive processes, though underlying mechanisms require further studyLencer R et al2003Eye-tracking dysfunctionSchizophreniaEye-tracking dysfunction may result from motion perception deficits involving cortical areas (V5, frontal eye field) and extraretinal mechanisms. Weak correlations with neuropsychological deficits suggest shared pathways with sensory gating and deficit syndromeLi W et al2015Abnormalities in processing visual informationAnorexia nervosa (AN), body dysmorphic disorder (BDD)AN and BDD show hypoactivity in dorsal visual stream for low spatial frequencies, indicating deficits in holistic processing. BDD shows hyperactivity for high spatial frequency houses, suggesting magnocellular pathway deficits contributing to distorted perceptionsLittlejohns TJ et al2022Visual impairment/visual acuityDementiaImpaired visual processing may directly affect cognition through sensory deprivation or information degradation. Retinal nerve fiber layer thinning, abnormal pupillary response, and contrast sensitivity are proposed dementia biomarkersLiu Y et al2020Ocular neurovascular diseases (AMD, central serous retinopathy, retinal vascular occlusion, diabetic retinopathy, glaucoma, dry eye syndrome, optic neuropathy)Schizophrenia, bipolar disorder, major depressive disorderGlaucoma’s link to psychiatric disorders may involve shared pathophysiology, with closed-angle glaucoma tied to structural abnormalities and open-angle glaucoma to neural processes, requiring further mechanistic investigationLiu Y et al2015Retinal nerve fiber layer (RNFL) thickness changesMild cognitive impairment, Alzheimer’s diseaseRNFL thinning in superior and inferior quadrants correlates with Alzheimer’s disease progression and amyloid-β accumulation. Mild cognitive impairment shows similar RNFL changes, suggesting early visual pathway involvementMakin SM et al2013Complex visual hallucinations (CVH) and attentional performanceDementia, eye diseaseVisual hallucinations in dementia are linked to impaired visual attention and perception, but not in eye disease, suggesting different or dynamic mechanisms despite similar hallucination contentMandas A et al2014Age-related vision disorders (macular degeneration)Mild cognitive impairment, mixed dementia, vascular dementia, Alzheimer’s diseaseMacular degeneration and dementia share nerve cell loss and neurodegenerative pathophysiology, with associations more evident in older populationsMeyhofer I et al2015Deficits in smooth-pursuit eye movements (SPEM)SchizotypyHigh schizotypy groups show lower BOLD signals in occipital regions (V5, fusiform gyrus, V3A) during SPEM, indicating motion perception deficits. Protective factors like increased prefrontal cortical thickness may reduce schizophrenia riskMitropoulou V et al2011Eye-tracking impairmentSchizophrenia, schizotypal personality disorderSchizophrenia patients show greater eye tracking impairment than controls and relatives, with schizotypal personality disorder intermediate. Differences are unrelated to age or symptomatology, possibly due to task velocity or genetic factorsMoore P et al2016Neuromyelitis opticaCognitive impairmentsCognitive impairment in neuromyelitis optica is associated with neurological disability but not disease duration, highlighting the need to study depression and cognitive comorbidities for early interventionMoretti R et al2020Visual hallucinations, ocular pathologies (glaucoma, macular degeneration, hypertensive/diabetic retinal complications)Subcortical vascular dementiaOcular pathologies in subcortical vascular dementia are linked to worse functional outcomes and reduced apathy compared to those without ocular issues, with white matter rarefactions associated with hallucinationsMoschos MM et al2011Anatomical/functional impairment of retina and optic nerve, macular/RNFL thicknessAnorexia nervosa (AN)AN patients show decreased macular and RNFL thickness, possibly due to impaired dopaminergic neurotransmission rather than vitamin A deficiency, with greater foveal impairment in the binge–purge subtypeMurgatroyd C et al2001Visual hallucinosis and visual sensory statusDementiaVisual hallucinosis is associated with poorer visual acuity and performance on clock drawing/object recognition tests, suggesting low vision as a contributing factor to disturbed behaviorNam GE et al2021Retinal vein occlusionDementiaRetinal vein occlusion is associated with Alzheimer’s disease risk, linked to reduced macular blood flow, sparser microvascular networks, and cerebral small vessel disease, particularly in hypertensive individuals Summary characteristics of included studies Quality assessment of included studies The methodological quality of the 17 included studies was evaluated using the Joanna Briggs Institute (JBI) Critical Appraisal Tool for case–control studies, focusing on criteria such as group comparability, exposure measurement, confounder management, and statistical appropriateness. Six studies were rated as low risk of bias, demonstrating robust design with clear matching of cases and controls, reliable outcome measures, and adjustment for confounders [e.g., [11, 13–17]. The remaining 11 studies were assessed as moderate risk, primarily due to unclear or absent matching procedures, limited confounder adjustment, or cross-sectional designs that restricted evaluation of exposure duration [18–20]. No studies were classified as high risk. These findings indicate a generally acceptable methodological quality but highlight the need for improved confounder management and longitudinal designs in future research to strengthen causal inferences. The risk-of-bias assessment is summarized in supplementary Table 1. Thematic synthesis of ocular abnormalities by disorder Across disorders, several findings suggested possible underlying pathways, though detailed mechanisms are reserved for later discussion. For instance, in schizophrenia, the frequent observation of smooth-pursuit eye movement deficits and color vision abnormalities may reflect dopaminergic and cortical circuit dysfunction. In bipolar disorder and major depression, the clustering of glaucoma, RNFL thinning, and dry eye syndrome points to potential vascular and inflammatory contributions. Similarly, in dementia, the consistent association between RNFL loss and disease progression raises the possibility of neurodegenerative mechanisms mirrored in retinal structures. These mechanistic links are introduced here to contextualize the observed patterns, with a more detailed exploration provided in the Discussion. Schizophrenia Across included studies, schizophrenia was consistently linked to visual-processing and retinal-structural abnormalities. Common findings comprised reduced contrast sensitivity, impaired smooth-pursuit eye movements (SPEM), and significant RNFL thinning. Eye-tracking dysfunctions were associated with disrupted activation of the frontal–striatal–thalamic circuitry and motion-perception pathways, consistent with dopaminergic dysregulation mechanisms reported and related evidence from the included literature [21]. Together, these data suggest that visual-pathway alterations may serve as peripheral correlates of cortical dysconnectivity in schizophrenia. Bipolar disorder and major depression Patients with bipolar disorder and major depression exhibited increased rates of glaucoma, dry eye syndrome, and RNFL thinning. Some studies suggested that systemic inflammation, medication effects, and vascular dysregulation may mediate these associations. Retinal microvascular changes and reduced macular perfusion were also reported in OCT-based studies. Dementia and cognitive impairment Visual deficits in dementia included severe visual acuity loss, visual hallucinations, retinal vascular occlusion, and macular degeneration. RNFL thinning was consistently associated with cognitive decline, particularly in Alzheimer’s disease, and correlated with disease progression. Retinal biomarkers were proposed as potential non-invasive indicators of neurodegeneration. Anorexia nervosa and body dysmorphic disorder In anorexia nervosa, structural changes in the retina such as increased macular thickness and altered RNFL profile were observed, potentially related to dopaminergic dysfunction and nutritional deficiency. Body dysmorphic disorder is characterized by altered visual processing pathways, with a preference for local over global spatial processing. Cross-disorder visualization: heatmap interpretation To synthesize the associations between psychiatric diagnoses and ocular abnormalities, we constructed a disorder-to-ocular pathology matrix (Fig. 2). This binary heatmap depicts the presence or absence of reported associations across disorders. Key insights include: schizophrenia demonstrated the broadest ocular involvement, with six distinct abnormalities including contrast-sensitivity deficits, eye-tracking dysfunction, color vision defects, and RNFL thinning. Bipolar disorder and major depression shared similar ocular profiles, notably glaucoma, RNFL thinning, and dry eye syndrome. Dementia was distinctly associated with retinal vascular pathology, macular degeneration, and visual hallucinations, highlighting its neurodegenerative and vascular basis. Anorexia nervosa and BDD showed more selective abnormalities focused on retinal layer integrity and visual information processing deficits.Fig. 2Disorder–ocular pathology matrix. A visual synthesis of associations between major psychiatric disorders and ocular pathologies based on evidence from included studies. Each cell represents the presence (orange-red) or absence (pale yellow) of a reported association between a specific disorder and ocular outcome. The matrix illustrates that schizophrenia shows the broadest ocular involvement, including contrast-sensitivity deficits, eye-tracking dysfunction, and retinal nerve fiber layer (RNFL) thinning. Bipolar disorder and major depression share overlapping features such as glaucoma, dry eye syndrome, and RNFL changes, while dementia is characterized by retinal vascular occlusion, visual acuity loss, and hallucinations. Anorexia nervosa (AN) and body dysmorphic disorder (BDD) are included to represent additional neuropsychiatric conditions exhibiting retinal and visual processing alterations. The figure highlights cross-disorder neuro-ophthalmic signatures supporting a shared brain–retina axis across psychiatric and cognitive spectra Disorder–ocular pathology matrix. A visual synthesis of associations between major psychiatric disorders and ocular pathologies based on evidence from included studies. Each cell represents the presence (orange-red) or absence (pale yellow) of a reported association between a specific disorder and ocular outcome. The matrix illustrates that schizophrenia shows the broadest ocular involvement, including contrast-sensitivity deficits, eye-tracking dysfunction, and retinal nerve fiber layer (RNFL) thinning. Bipolar disorder and major depression share overlapping features such as glaucoma, dry eye syndrome, and RNFL changes, while dementia is characterized by retinal vascular occlusion, visual acuity loss, and hallucinations. Anorexia nervosa (AN) and body dysmorphic disorder (BDD) are included to represent additional neuropsychiatric conditions exhibiting retinal and visual processing alterations. The figure highlights cross-disorder neuro-ophthalmic signatures supporting a shared brain–retina axis across psychiatric and cognitive spectra This heatmap helps visualize shared versus disorder-specific visual signatures, suggesting that retinal biomarkers may cluster along neurodevelopmental and neurodegenerative axes. Discussion This systematic review provides a comprehensive synthesis of ocular abnormalities across major psychiatric disorders, revealing consistent yet under-recognized patterns of retinal and visual dysfunction. The findings suggest that the eye, specifically the retina and its microvascular and neuroaxonal structures, may serve as a peripheral extension of the brain’s pathophysiology. Disorders such as schizophrenia, bipolar disorder, and dementia demonstrate distinct yet overlapping ocular signatures, including retinal nerve fiber layer thinning, contrast-sensitivity deficits, and retinal vascular compromise. These abnormalities not only reflect possible shared neurovascular, inflammatory, and neurodegenerative mechanisms, but also highlight the potential for retinal imaging to serve as a non-invasive biomarker platform in psychiatric care. By systematically mapping these associations, our review underscores the need to incorporate visual system evaluation into both research frameworks and clinical algorithms for mental health (Table 2). Compared with prior reviews that examined isolated disorders or single imaging modalities, this study provides the first comprehensive synthesis across major psychiatric and neuropsychiatric conditions. Earlier works, such as Silverstein et al. and Komatsu et al. [4, 22], highlighted the potential of retinal imaging as a biomarker but focused primarily on schizophrenia or Alzheimer’s disease. In contrast, the present review integrates findings from multiple diagnostic categories, schizophrenia, bipolar disorder, depression, dementia, and related disorders, while incorporating both structural and functional visual parameters. By consolidating these fragmented lines of evidence, our work establishes a unified framework for understanding the brain–retina axis in psychiatry and identifies cross-diagnostic retinal biomarkers warranting future validation. Cognitive impairment As previously outlined in the Introduction and Results, the interaction between cognitive decline and visual impairment has already been established; this section therefore focuses on mechanistic and theoretical interpretations rather than restating prior findings. Visual impairment and cognitive decline Lee et al. [13] suggest that poor visual acuity might lead to decreased visual input, thus weakening the neuronal networks that support cognitive processes [13]. Raman et al. [23] add that glaucoma-related visual impairment is linked to lower cognitive scores due to reduced participation in cognitively stimulating activities [23]. They also discuss how fixation loss (FL), often due to improper head positioning, is a common cause of unreliable visual field (VF) tests, particularly in older patients [23]. These cognitive processes involve attention, memory, and executive functioning, and declines in these areas are reflected in increased false-negative (FN) response rates [23]. Theories on cognitive decline Zheng et al. [24] propose two theories to explain the association between visual impairment and cognitive decline [24]. The sensory loss consequence theory posits that poor vision reduces brain stimulation by limiting participation in enriching activities, leading to cognitive decline [24]. The second hypothesis suggests that visual acuity (VA) and cognitive function decline stem from common causes, such as central nervous system degeneration or inflammation [24]. Their findings support the sensory loss consequence theory, indicating that vision has a significant impact on cognitive function [24]. Visual hallucinations and cognitive decline Makin et al. [25] suggest that visual hallucinations in different disorders might share a common mechanism involving impairments in visual object attention and perception [25]. They propose that dynamic factors or mechanisms may affect eye diseases and dementia [25]. Murgatroyd and Prettyman [18] note that low vision can cause both visual hallucinations and disturbed behavior, highlighting the need to consider visual acuity in neuropsychological evaluations [18]. Cataracts and cognitive function Paik et al. [26] report that cataracts, common in older adults, can impair vision significantly, leading to cognitive decline by reducing sensory input and social interactions [26]. Early intervention, such as cataract surgery, is beneficial in preventing these adverse effects [26]. Myopia and social behavior Sun et al. [27] indicate that myopic individuals tend to exhibit personality traits such as introversion, leading to reduced social and physical activities and increasing the risk of cognitive decline [27]. The classification of eye diseases and their impact on cognitive decline underscores the need for integrated healthcare approaches. By addressing visual and cognitive health through regular ocular evaluations, early interventions, and the management of systemic conditions, overall well-being and cognitive function can be improved. Future research should focus on these relationships to develop comprehensive diagnostic and therapeutic strategies, enhancing outcomes for individuals with neurodegenerative and psychiatric disorders. Feeding and eating disorders: Anorexia nervosa (AN) and body dysmorphic disorder (BDD) Moschos et al. [19] highlight that decreased appetitive function in anorexia nervosa (AN) may stem from impaired dopaminergic neurotransmission, which is crucial for visual pathways [19]. Dopamine deficiency can affect retinal ganglion cells, leading to issues in glutamate production and thinning of the retinal nerve fiber layer (RNFL) [19]. They also found that restrictive-type AN patients have higher retinal thickness than binge-purge-type AN patients, indicating more significant foveal impairment in the latter [19]. The study rules out vitamin A deficiency as a cause for retinal issues, suggesting other nutritional abnormalities or impaired dopaminergic transmission [19]. Li et al. [28] found that both AN and body dysmorphic disorder (BDD) show reduced activity in the brain's dorsal visual stream for low spatial frequency images, affecting early and later visual processing [28]. However, BDD participants displayed increased activity in the ventral stream for high spatial frequency images of houses but decreased activity for low spatial frequency faces compared to AN [28]. This suggests a deficit in the magnocellular pathway, impacting holistic visual perception and contributing to distorted body perceptions [28]. The study indicates that disorders involving appearance distortion share a common visual processing trait, leading to focused attention on perceived flaws without seeing the bigger picture [28]. Neural differences tied to event-related potential (ERP) components emerge early, hinting at abnormalities in visual regions before the information reaches areas handling memory, emotion, and cognition [28]. Anxiety Depression, anxiety, and physical sensations Szakáts et al. [29] highlighted the impact of depression and anxiety on physical sensations, noting that these mental health conditions can lower pain thresholds and heighten sensitivity to physical symptoms [29]. This increased sensitivity can exacerbate anxiety, potentially leading to more frequent patient–physician interactions [29]. Understanding this cycle is vital for developing comprehensive treatment plans that address these conditions’ psychological and physical aspects, thereby improving patient outcomes [29]. Anxiety disorders in high myopia patients post-cataract surgery Yokoi et al. [30] conducted a multivariate logistic regression analysis to identify factors associated with anxiety disorders in patients with high myopia [30]. They found that a history of cataract surgery was significantly linked to the presence of anxiety disorders [30]. This association is likely due to the younger age at which cataract surgery is performed in high myopia patients, aiming not only to treat the cataract, but also to alleviate the anxiety caused by worsening myopia [30]. This finding emphasizes the importance of considering psychological factors when planning and conducting cataract surgeries in patients with high myopia [30]. The studies by Smyrnis et al. [31], Szakáts et al. [29], and Yokoi et al. [30] collectively highlight the intricate connections between eye diseases, mental health, and physical sensations [29–31]. By understanding these relationships, healthcare providers can tailor their treatment approaches more effectively, ensuring that patients’ psychological and physiological needs are met. This holistic approach is crucial for enhancing patient care and outcomes in individuals with complex eye and mental health conditions. Schizophrenia Schizophrenia and visual impairment Avsar et al. [20] found that patients with schizophrenia exhibit decreased activation in a frontal–striatal–thalamic neuronal network, which includes critical brain regions like the pre- and post-central cortices, thalamus, and globus pallidus [20]. Additionally, these patients showed reduced activation of occipital and lateral temporal cortices during cognitive tasks [20]. This reduction in activation, supported by data from Hong et al. [14], suggests a potential mechanism where motion perception deficits in schizophrenia are linked to impairments in generating and integrating smooth-pursuit eye movement (SPEM)-induced extraretinal motion signals [14]. Latham et al. [32] further add that the pursuit system’s impairment in schizophrenia is not solely due to brainstem involvement but could also be attributed to cortical dysfunction, particularly in the parietal association cortex [32]. Meyhöfer et al. [33] observed that pursuit eye movements activate brain pathways involving visual, frontal, and parietal areas [33]. High schizotypy groups had lower BOLD signals in occipital regions during pursuit eye movements, highlighting potential deficits in motion perception [33]. Eye tracking dysfunction and schizophrenia Lancer et al. [34] highlight that ETD (eye tracking dysfunction) in schizophrenia might be due to motion perception deficits involving cortical areas like V5 in the occipital–parietal–temporal region and the frontal eye field [34]. They also indicate a weak correlation between ETD and neuropsychological deficits in schizophrenia, suggesting that ETD shares common pathophysiological pathways with poor sensory gating and deficit syndrome in schizophrenia [34]. Smyrnis et al. [31] further demonstrate that relatives with ETD showed less activation in the frontal eye fields than those with everyday pursuit [31]. Changes in visual function and schizophrenia González-Hernández et al. [35] discuss the involvement of multiple visual generator deficits in schizophrenia, linking dysfunctions in medial OT, parahippocampus, cuneus, precuneus, superior parietal, and posterior cingulum [35]. These areas function as nodes driving dysfunction in interconnected regions, suggesting an essential underlying visual dysfunction as a root cause of various visual and cognitive aberrations [35]. Grove et al. [15] advocate for cognitive remediation focusing on visual integration tasks to improve occipital cortical functions and higher-order cognition impacted by poor early visual processing in psychosis [15]. They suggest applying brain stimulation techniques such as transcranial direct-current stimulation (tDCS) paired with neuroplasticity-based cognitive training to enhance therapeutic outcomes [15]. Visual processing deficits in schizophrenia Shoham et al. [36] note that suboptimal correction of refractive errors, degenerative neuronal alterations in the retina, or factors like diabetes, hypertension, and antipsychotic medications can cause visual impairment in schizophrenia [36]. They emphasize that visual impairment might act as a risk factor for psychotic experiences in older adults, although the effect is small and may reflect shared central nervous system dysfunction rather than a causal relationship [36]. Ross et al. [37] add that abnormal smooth-pursuit eye movements and the deficit syndrome share a common pathophysiology, involving decreased metabolism in the frontal and parietal association cortex and altered caudate nucleus metabolism [37]. Emerging retinal imaging techniques and psychiatric screening Recent advances in retinal imaging, particularly optical coherence tomography angiography (OCT-A), have enabled high-resolution, non-invasive visualization of the retinal microvasculature. OCT-A enables the quantification of capillary density, perfusion, and foveal avascular zone (FAZ) morphology, metrics that are increasingly recognized as surrogates for cerebral microcirculation integrity. In psychiatric populations, OCT-A studies have begun to reveal microvascular rarefaction and capillary dropout, especially in schizophrenia and major depressive disorder, consistent with broader vascular hypotheses of mental illness [38]. This technology holds promise as a biomarker platform for neuropsychiatric disorders, given the retina’s embryological origin from the diencephalon and shared blood–brain barrier properties. Its integration into psychiatric assessments may facilitate early detection of neurovascular dysfunction, aid in risk stratification, and support longitudinal monitoring, particularly in disorders with progressive trajectories such as schizophrenia and dementia. Brain–retina axis: a bidirectional neurovascular interface Emerging evidence supports the brain–retina axis as a functional unit, whereby pathological changes in the central nervous system are mirrored in retinal morphology and vasculature. Studies have shown correlations between retinal nerve fiber layer (RNFL) thinning and cognitive decline, including associations with hippocampal atrophy and white matter hyperintensities [39, 40]. Additionally, retinal biomarkers such as venular tortuosity, fractal dimension, and arteriovenous ratio have been implicated in Alzheimer’s disease, vascular dementia, and psychotic disorders [39]. These findings position the retina as a readily accessible window to cerebral pathology, providing an opportunity for non-invasive screening tools that bridge neurology and psychiatry. Incorporating retinal assessments into psychiatric practice may augment the predictive value of neuroimaging and cognitive testing, especially in resource-constrained settings. Pharmacologic confounders: ocular effects of psychotropic medications The potential interaction between medication exposure, disease severity, and ocular manifestations was considered in detail. Psychotropic medications, particularly antipsychotics, mood stabilizers, and antidepressants, can independently impact ocular health, posing a potential confounder in observed associations. For example, the anticholinergic effects of first-generation antipsychotics can reduce tear production and exacerbate dry eye disease. At the same time, long-term use of phenothiazines has been associated with corneal and lenticular pigmentation. Second-generation antipsychotics such as olanzapine and quetiapine have been implicated in metabolic syndrome, which increases the risk for diabetic retinopathy and glaucoma [41, 42]. Lithium has been linked to blurred vision and nystagmus, and selective serotonin reuptake inhibitors (SSRIs) have been associated with intraocular pressure elevation, particularly in angle-closure glaucoma. These ocular side effects can mimic or mask the underlying neurovascular manifestations of psychiatric illness, underscoring the importance of differentiating drug-induced changes from disease-related pathology. Future studies should incorporate medication history, dosage, and duration as covariates to clarify the direct contributions of psychiatric pathology to ocular findings. The absence of quantitative synthesis underscores a critical gap in current literature, namely, the lack of standardized, longitudinal studies with harmonized imaging and diagnostic protocols. Future research must prioritize prospective designs that integrate retinal imaging, cognitive testing, and psychiatric evaluation to validate candidate biomarkers such as RNFL thinning and microvascular dropout. Establishing reproducible, cross-cohort biomarker frameworks will be essential for translating these observations into clinical tools. Implications for healthcare policy The findings of this review underscore the urgent need to integrate ocular assessments into standard psychiatric care. Despite increasing evidence linking psychiatric disorders to ocular pathology, no formal screening guidelines currently exist within major psychiatric (e.g., APA) or ophthalmologic (e.g., AAO) societies addressing vision health in mentally ill populations. We propose the following clinical considerations: Routine ophthalmologic screening (including visual acuity testing and fundus examination) for patients with schizophrenia, bipolar disorder, and dementia, especially those over age 50 or on long-term antipsychotics [43]. Annual OCT or OCT-A in patients with bipolar disorder or major depressive disorder who also have vascular risk factors (e.g., diabetes, hypertension) [44, 45]. Baseline visual field testing and RNFL evaluation in newly diagnosed dementia or mild cognitive impairment cases to track visual–cognitive interplay. Addressing this gap could reduce the burden of undiagnosed ocular disease, improve quality of life, and offer early neurodegenerative biomarkers. Policymakers and guideline committees should recognize vision health as a psychiatric comorbidity, warranting the development of cross-disciplinary screening frameworks [46]. Future revisions of care protocols (DSM, NICE, or AAO guidelines) should include interdisciplinary referral pathways between psychiatry, neurology, and ophthalmology. Research funding should prioritize the validation of retinal biomarkers in mental illness and the development of targeted screening algorithms based on risk stratification [46]. While integrating ocular screening into psychiatric care shows strong diagnostic potential, feasibility and cost-effectiveness must guide implementation. Routine optical coherence tomography (OCT) or OCT-angiography may not be financially or logistically viable in all settings, particularly in low- and middle-income countries. A tiered approach is therefore more practical: basic visual-acuity and fundus examinations can serve as initial screening tools in psychiatric clinics, with advanced imaging reserved for high-risk or symptomatic patients. Cost–benefit analyses in ophthalmology have shown that early detection of retinal pathology can offset expenses by reducing vision-related disability and improving treatment adherence. Future studies should formally evaluate the economic impact and scalability of integrating ocular assessments into psychiatric protocols to ensure equitable, sustainable implementation across health systems. While the identification of ocular biomarkers offers promising opportunities for early detection and monitoring of psychiatric disorders, it also raises important ethical considerations. Labeling individuals with retinal or ocular findings as “at risk” for psychiatric illness could inadvertently contribute to stigma, discrimination, or anxiety, particularly if predictive value remains uncertain. Such labeling risks reinforcing stereotypes of psychiatric vulnerability and may discourage individuals from seeking ophthalmologic care. To mitigate these concerns, strategies should emphasize patient education, clear communication of the limitations of biomarker-based predictions, and the framing of ocular assessments as complementary rather than deterministic tools. Incorporating shared decision-making, protecting patient confidentiality, and promoting interdisciplinary counseling can help ensure that ocular findings are contextualized within a broader clinical picture. By prioritizing transparency and stigma reduction, the integration of ocular screening into psychiatric care can proceed in a manner that benefits patients without compounding existing social or psychological burdens. Suggested frameworks are pending validation. Integrating cross-specialty care and interdisciplinary training To bridge the gap between psychiatric and ocular health, structural changes in training and service delivery are essential. We recommend the development of interdisciplinary educational modules for psychiatry, neurology, and ophthalmology trainees that cover neuro-ophthalmic manifestations of mental illness, ocular side effects of psychotropic medications, and retinal imaging interpretation in psychiatric populations [47]. In parallel, healthcare systems should explore cross-specialty referral models, including: neuro-ophthalmology clinics embedded in mental health centers, bidirectional referral pathways between psychiatry and ophthalmology departments, integrated electronic health records flagging high-risk psychiatric patients for vision screening. These models can improve early detection, reduce misdiagnosis of ocular symptoms, and promote collaborative care planning. Institutional support for these integrative pathways may help translate the emerging science of brain–retina relationships into clinical action and policy reform. Addressing gaps and guiding future directions This review addresses a critical gap in the psychiatric and ophthalmologic literature by systematically synthesizing evidence on the visual and retinal manifestations of major psychiatric disorders, an area previously scattered across small, siloed studies. While isolated reports have hinted at ocular changes in schizophrenia, dementia, and mood disorders, our cross-disorder synthesis reveals recurring, measurable retinal signatures such as RNFL thinning and retinal vascular changes, which transcend diagnostic categories. By highlighting these shared patterns, we propose a novel diagnostic lens through which psychiatric illness may be evaluated not only by behavioral and neuroimaging criteria, but also through non-invasive retinal biomarkers. This framework encourages future research to develop integrated diagnostic models that incorporate ocular imaging, explore longitudinal progression of retinal changes, and validate their utility in early screening, treatment monitoring, and disease subtyping. Bridging this gap may ultimately facilitate more holistic, biologically anchored approaches to mental health diagnostics. Limitation While examining the risk of ocular pathologies in psychiatric disorders is a valuable and emerging area of research, several limitations must be acknowledged. A key challenge lies in the cross-sectional design of most included studies, which prevents causal inference. In such designs, reverse causation cannot be ruled out—for instance, visual impairment might exacerbate psychiatric symptoms through social withdrawal or cognitive strain, while psychiatric illness itself may contribute to ocular changes via neurovascular or inflammatory mechanisms. Longitudinal studies are required to disentangle these bidirectional pathways and clarify temporal relationships. Another major limitation involves psychotropic medications, which can independently influence ocular physiology. Antipsychotics, antidepressants, and mood stabilizers have been linked to effects on intraocular pressure, tear production, and retinal metabolism, potentially confounding observed associations. Because medication regimens, dosages, and treatment durations varied widely across studies, their impact could not be adequately isolated. Future research should employ stratified or sensitivity analyses by medication class and treatment duration to differentiate disorder-related effects from pharmacologic ones. The heterogeneity of psychiatric disorders adds further complexity, as these conditions differ in biological mechanisms, disease progression, and treatment approaches. Variations in diagnostic criteria (e.g., DSM versus ICD) and outcome definitions reduce comparability and generalizability. Similarly, ocular pathologies such as glaucoma, dry eye disease, and retinopathy have distinct etiologies that may not be uniformly influenced by psychiatric states. The relatively small number of eligible studies and limited sample sizes within individual cohorts also constrain the strength and generalizability of our conclusions. This limitation reflects the current scarcity of high-quality, imaging-based research in psychiatric populations rather than any methodological restriction of the present review. The small evidence base underscores an urgent need for large-scale, multicenter, and longitudinal studies employing standardized diagnostic criteria and imaging protocols to validate the emerging retinal and ocular biomarkers identified here. The restriction to English-language publications may have introduced language bias, while the lack of longitudinal data limits causal interpretation. Additionally, although the search strategy covered a wide range of psychiatric disorders, most included studies centered on major categories such as schizophrenia, bipolar disorder, depression, and dementia. The paucity of data on anxiety and other underrepresented conditions suggests a research gap rather than deliberate omission. Publication bias may persist, as studies with null findings are less likely to be published. Mechanistic research is also limited, hindering our understanding of the biological pathways linking psychiatric and ocular health. Addressing these challenges will require standardized diagnostic frameworks, comprehensive medication reporting, and prospective multimodal designs integrating ophthalmologic, neuroimaging, and behavioral data. Supplementary Information Supplementary material 1 Supplementary material 1